Mechanisms involved in inflammatory pulmonary fibrosis induced by lunar dust simulant in rats

Atmospheric environment shapes surface reactivity of Fe(0)-doped lunar dust simulant: Potential toxicological implications

The toxicity of lunar dust (LD), anecdotally reported by Apollo astronauts, raises concerns for future missions involving prolonged human presence on the Moon. LD toxicity is thought to involve oxidative stress driven by nanophase metallic iron (np-Fe0), a peculiar feature of LD. In life-supporting lunar habitat, np-Fe0 embedded in the amorphous phases of LD may react with O2 prior to accessing the lung, complicating toxicity assessments. Due to limited availability of real LD samples, toxicological evaluations rely on lunar dust simulants (LDS). A novel Simulant Moon Agglutinate (SMA), composed of a glassy matrix with np-Fe0, was produced and ball milled in an inert atmosphere to expose non-oxidized Fe0 surface centers and to obtain a dust with respirable particle size. Physicochemical properties, oxidative activity, and iron release in simulated body fluids were assessed on selected SMA samples. SMA were aged in air, and the kinetics of free radical generation revealed a strong redox activity that decreased with aging. After an oxidative ageing of 1 month, SMA was still active in generating free radicals, to a higher extent that other LD simulants like JSC-1A-vf, highlighting the key role of np-Fe0 in eliciting LD peculiar reactivity. In vitro tests showed that SMA caused no cell membrane damage, suggesting that LD toxicity mechanisms might involve free radicals and may differ from terrestrial toxic dust, such as quartz.

Lunar dust induces minimal pulmonary toxicity compared to Earth dust

Humans are returning to the moon and understanding the toxicity of lunar dust is crucial for successful missions. Apollo mission reports suggest that lunar dust poses significant inhalation risks. Previous studies on lunar dust simulants have shown tissue and cellular damage in the lungs. This study focuses on two new simulants, LMS-1 and LHS-1, which closely replicate the lunar dust of the mare and highland regions of the moon. BEAS-2B and A549 cells were treated with unprocessed LMS-1 and LHS-1 (100µg/ml, 1000µg/ml and 5000µg/ml). The simulants were processed to isolate particles ≤2.5 µm, allowing a direct comparison to Earth dust (airborne particulate matter). BEAS-2B and A549 cells were treated with processed simulants and Earth dust (10µg/ml, 50µg/ml, and 100µg/ml) for 48 and 72 h. Inflammation was measured by measuring IL-6 and IL-8 using ELISA and cell viability was measured using a trypan blue exclusion test. A time- and dose-dependent increase in IL-8 and IL-6 production by LMS-1 and LHS-1 exposure was found only in BEAS-2B cells. A dose-dependent decrease in cell viability was found in both BEAS-2B and A549 cells with lunar dust simulant exposure. Particles ≤2.5 µms cause greater cell death than particles ≤1000µm. However, Earth dust induced greater cytokine release and was more toxic than lunar dust simulants. Lunar dust simulants did not increase SOD2 gene expression, indicating no increases in oxidative stress in either cell type. Therefore, our results suggest that lunar dust simulants are not highly toxic dusts, but rather a physical irritant. Future studies are needed to confirm the relative toxicity and irritant capacity of other lunar regions simulants.

Preventive Effects of Vanillic Acid Against Lung Inflammation and Oxidative Stress Induced by Dust Particles in Wistar Rats

To evaluate dose-dependent cytotoxicity effects of indoor dust particles (DPs) collected from Neyshabur, Iran, in vitro on A545 cells and in vivo on lungs of healthy male Wistar rats, as well as the antioxidant effects of vanillic acid (VA) against DP inhalation. Heavy metal levels in DPs collected from high-traffic (HT), medium-traffic, low-traffic or rural (LT) zones were measured, and their cytotoxicity effects were evaluated by MTT assay. In vivo evaluations were conducted after rats were exposed to DPs collected from HT or LT in the presence or absence of VA. Exposure to DPs increased the activity of serum superoxide dismutase; the serum level of malondialdehyde; and mRNA expression of TNFα, IL6, CXCL15 and CYP1A1 in the lung homogenate groups receiving HT and LT compared to the control group. DP effects in the groups receiving HT were higher than those of LT. Concomitant VA intake attenuated the adverse effects mediated by DPs in the HT and LT groups. DPs had adverse effects on the lungs of healthy rats, probably because of the accumulated oxidative stress agents. VA could ameliorate the effects of DPs and may be considered as a protective substance against the undesirable effects of DPs.

Assessment of toxicity changes induced by exposure of human cells to lunar dust simulant

The toxicity of lunar dust (LD) to astronauts' health has been confirmed in the Apollo missions and subsequent biological experiments. Therefore, it is crucial to understand the biological toxicity of lunar dust for future human missions to the Moon. In this study, we exposed human lung epithelial cells (BEAS-2B) and peripheral blood B lymphocytes (AHH-1) to varying concentrations (0, 500, 1000, and 1500 μg/ml) of a lunar dust simulant (LDS) called CLDS-i for 24 and 48 h. The results provided the following key findings: (1) LDS induction of cell damage occurred through oxidative stress, with the levels of reactive oxygen species (ROS) in BEAS-2B cells being dependent on the duration of exposure. (2) Necrosis and early apoptosis were observed in BEAS-2B cells and AHH-1 cells, respectively. In addition, both cells showed lysosomal damage. (3) Genes CXCL1, SPP1, CSF2, MMP1, and POSTN are implicated in immune response and cytoskeletal arrangement regulation in BEAS-2B cells. Considering the similarities in composition and properties between CLDS-i and real lunar dust, our findings not only enhance the understanding of LDS toxicity, but also contribute to a better comprehension of the genomic alterations and molecular mechanisms underlying cellular toxicity induced by LD. These insights will contribute to the development of a biotoxicology framework aimed at safeguarding the health of astronauts and, consequently, facilitating future human missions to the Moon.

Toxic effect and mRNA mechanism of moon dust simulant induced pulmonary inflammation in rats

Moon dust presents a significant hazard to manned moon exploration missions, yet our understanding of its toxicity remains limited. The objective of this study is to investigate the pattern and mechanism of lung inflammation induced by subacute exposure to moon dust simulants (MDS) in rats. SD rats were exposed to MDS and silica dioxide through oral and nasal inhalation for 6 hours per day continuously for 15 days. Pathological analysis indicated that the toxicity of MDS was lower than that of silica dioxide. MDS led to a notable recruitment and infiltration of macrophages in the rat lungs. Material characterization and biochemical analysis revealed that SiO2, Fe2O3, and TiO2 could be crucial sources of MDS toxicity. The study revealed that MDS-induced oxidative stress response can lead to pulmonary inflammation, which potentially may progress to lung fibrosis. Transcriptome sequencing revealed that MDS suppresses the PI3K-AKT signaling pathway, triggers the Tnfr2 non-classical NF-kB pathway and IL-17 signaling pathway, ultimately causing lung inflammation and activating predominantly antioxidant immune responses. Moreover, the study identified the involvement of upregulated genes IL1b, csf2, and Sod2 in regulating immune responses in rat lungs, making them potential key targets for preventing pulmonary toxicity related to moon dust exposure. These findings are expected to aid in safeguarding astronauts against the hazardous effects of moon dust and offer fresh insights into the implications and mechanisms of moon dust toxicity.

Mechanism of simulated lunar dust-induced lung injury in rats based on transcriptomics

Lunar dust particles are an environmental threat to lunar astronauts, and inhalation of lunar dust can cause lung damage. The current study explored the mechanism of lunar dust simulant (CLDS-i) inducing inflammatory pulmonary injury. Wistar rats were exposed to CLDS-i for 4 h/d and 7d/week for 4 weeks. Pathological results showed that a large number of inflammatory cells gathered and infiltrated in the lung tissues of the simulated lunar dust group, and the alveolar structures were destroyed. Transcriptome analysis confirmed that CLDS-i was mainly involved in the regulation of activation and differentiation of immune inflammatory cells, activated signaling pathways related to inflammatory diseases, and promoted the occurrence and development of inflammatory injury in the lung. Combined with metabolomics analysis, the results of joint analysis of omics were found that the genes Kmo, Kynu, Nos3, Arg1 and Adh7 were involved in the regulation of amino acid metabolism in rat lung tissues, and these genes might be the key targets for the treatment of amino acid metabolic diseases. In addition, the imbalance of amino acid metabolism might be related to the activation of nuclear factor kappaB (NF-κB) signaling pathway. The results of quantitative real-time polymerase chain reaction and Western blot further confirmed that CLDS-i may promote the occurrence and development of lung inflammation and lead to abnormal amino acid metabolism by activating the B cell activation factor (BAFF)/ B cell activation factor receptor (BAFFR)-mediated NF-κB signaling pathway.

Numerical analysis of micro lunar dust deposition in the human nasal airway

The toxicity of Lunar dust (LD) is well-known to harm astronauts' health. However, the characteristics of micro-LD deposition in the human nasal airway remains unknown, and studying it through experiments is challenging. Therefore, this study employs numerical investigations to address this issue. Our findings reveal that LD larger than 4 µm primarily (>50%) deposit in the nasal cavity at an inspiration flow rate of Q= 40 L/min, while LD smaller than 8 µm are more likely (>50%) to enter the lung lobe at Q= 15 L/min. The right upper lung lobe receives a higher deposit fraction of LD compared to other lobes, reaching a maximum of 31%. The ratio of deposition fraction in the right lung and left lung can reach to 3.0. Accurately predicting LD deposition in the upper airway and entire lung is possible using mathematical expressions, but the prediction becomes more challenging for the bronchial airway and lung lobes. These results indicate that micro-LD deposition characteristics in the human nasal airway are influenced by LD size and astronauts' activity level. The deposition fractions can be used to assess the health risk from lunar dust to astronauts and provide insights into developing protective measures against LD exposure.

Exploring the mechanism of lung injury induced by lunar dust simulant in rats based on metabolomic analysis

Inflammatory response and oxidative stress are considered to be important mechanisms of lung injury induced by lunar dust. However, the pulmonary toxicological mechanism remains unclear. In the present study, Wistar rats were exposed to CLDS-i 7 days/week, 4 h/day, for 4 weeks in the mouth and nose. Lung tissue samples were collected for histopathological analysis and ultra-performance liquid chromatography-mass spectrometry analysis. Enzyme activities and expression levels of key metabolic enzymes were detected by biochemical analysis and real-time PCR. The pathological features of lung tissue showed that CLDS-i caused congestion and inflammation in the lungs, and the lung structure was severely damaged. Metabolomics analysis showed that 141 metabolites were significantly changed in the lung tissue of the CLDS-i group compared with the control group. Combined with Kegg pathway analysis, it was found that the changes of amino acid metabolites were involved in these pathways, indicating that the simulated lunar dust exposure had the most obvious effect on amino acid metabolism in the lung tissue of rats. Real-time PCR analysis showed that the mRNA expression of six key enzymes related to amino acid metabolism was changed, and the enzyme activities of these key enzymes were also changed, which were consistent with the results of qPCR. These results suggest that changes in amino acid metabolism may be closely related to the pathogenesis of lung injury induced by lunar dust, and amino acid metabolism may be a potential biomarker of lung diseases related to lunar dust exposure.

A Dusty Road for Astronauts

The lunar dust problem was first formulated in 1969 with NASA's first successful mission to land a human being on the surface of the Moon. Subsequent Apollo missions failed to keep the dust at bay, so exposure to the dust was unavoidable. In 1972, Harrison Schmitt suffered a brief sneezing attack, red eyes, an itchy throat, and congested sinuses in response to lunar dust. Some additional Apollo astronauts also reported allergy-like symptoms after tracking dust into the lunar module. Immediately following the Apollo missions, research into the toxic effects of lunar dust on the respiratory system gained a lot of interest. Moreover, researchers believed other organ systems might be at risk, including the skin and cornea. Secondary effects could translocate to the cardiovascular system, the immune system, and the brain. With current intentions to return humans to the moon and establish a semi-permanent presence on or near the moon's surface, integrated, end-to-end dust mitigation strategies are needed to enable sustainable lunar presence and architecture. The characteristics and formation of Martian dust are different from lunar dust, but advances in the research of lunar dust toxicity, mitigation, and protection strategies can prove strategic for future operations on Mars.

Effects of lunar dust simulant on cardiac function and fibrosis in rats

The objective of this study was to investigate the effects of lunar dust simulant (LDS) on cardiac function and fibrosis. In an in vivo experiment, after 3 weeks of exposure, electrocardiography (ECG) and histopathological and immunohistochemical analyses of the cardiac tissue were performed. Systemic inflammatory markers and genes and proteins associated with cardiac tissue fibrosis were examined. In an in vitro experiment, fibrosis-related factors were detected in H9c2 cells by western blot and the mechanism of myocardial fibrosis by LDS exposure was explored. LDS exposure significantly altered heart rate indicators, implying altered cardiac and autonomic system functions. LDS dose-dependently increased the type and number of ECG abnormalities, and increased serum inflammatory factors. In addition, pathological changes in the myocardial tissue were observed through hematoxylin and eosin, Masson, and immunohistochemical staining; the expression of genes and proteins related to fibrosis in the myocardial tissue was also altered. These findings indicate that LDS exposure causes systemic inflammatory lesions that affect autonomic function, leading to inflammatory myocardial fibrosis. And its mechanisms involve the mediation of the nuclear factor-E2-related factor (Nrf2)/nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4) redox balance.